BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34010237)

  • 1. Do the 2013 United States Preventive Services Task Force guidelines for lung cancer screening fail high-risk African American smokers? An institutional retrospective observational cohort study.
    Thurlapati A; Velez-Martinez CS; Hirani S; Abad J; Shi R; Beedupalli K; Mansour RP
    Eur J Cancer Prev; 2021 Sep; 30(5):375-381. PubMed ID: 34010237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.
    Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC
    Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
    Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
    Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer.
    Olazagasti C; Ehrlich M; Kohn N; Aviles K; Hoilett A; Seetharamu N
    Cancer Control; 2022; 29():10732748221077959. PubMed ID: 35157547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving identification of candidates for lung cancer screening in a high risk population.
    Waddle MR; Ko SJ; May J; Kaleem T; Miller DH; Stross WC; Malouff TD; Wert K; Cuthbert K; Landy R; Strong G; Vallow LA; Johnson MM
    Lung Cancer; 2020 Oct; 148():79-85. PubMed ID: 32827761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
    Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
    JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-Based lung cancer screening: A systematic review.
    Toumazis I; Bastani M; Han SS; Plevritis SK
    Lung Cancer; 2020 Sep; 147():154-186. PubMed ID: 32721652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
    Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
    JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities of National Lung Cancer Screening Guidelines in the US Population.
    Han SS; Chow E; Ten Haaf K; Toumazis I; Cao P; Bastani M; Tammemagi M; Jeon J; Feuer EJ; Meza R; Plevritis SK
    J Natl Cancer Inst; 2020 Nov; 112(11):1136-1142. PubMed ID: 32040195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of Chronic Smoking Behavior and Eligibility for Low-Dose Computed Tomography for Lung Cancer Screening Among Older Chinese Male Smokers.
    Li CC; Matthews AK; Dong X
    J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(suppl_1):S22-S25. PubMed ID: 28575258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
    Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
    Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the revised LDCT lung cancer screening guideline bridge the racial disparities gap: Results from the health and retirement study.
    Li CC; Manella J; Kefi SE; Matthews AK
    J Natl Med Assoc; 2024 Apr; 116(2 Pt 1):180-188. PubMed ID: 38245469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.